Patents by Inventor Johann Willeit

Johann Willeit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICRORNA-122 IN METABOLIC DISEASES
    Publication number: 20190010547
    Abstract: The present invention relates to a predictive diagnostic method for identifying whether a patient will develop metabolic syndrome and/or type-2 diabetes in the future. In particular, the invention relates to a method for identifying a subject which has a risk for developing metabolic syndrome and/or type-2 diabetes, wherein the method comprises (a) analyzing (i.e. determining/measuring/quantifying) in a sample obtained from a test subject the amount of miR-122; and (b) identifying (i.e. detecting) a subject, which has a risk for developing metabolic syndrome and/or type-2 diabetes, wherein an increased amount of miR-122 as compared to the amount of miR-122 of a healthy reference population indicates a risk for developing metabolic syndrome and/or type-2 diabetes. Another aspect of the invention relates to a method for monitoring the therapeutic success during the treatment of metabolic syndrome and/or type-2 diabetes, wherein the method comprises (a) analyzing (i.e.
    Type: Application
    Filed: November 4, 2016
    Publication date: January 10, 2019
    Applicants: Medizinische Universität Innsbruck, King's College London
    Inventors: Peter Willeit, Manuel Mayr, Johann Willeit, Stefan Kiechl
  • Method for diagnosing the metabolic syndrome (MS)
    Patent number: 8137922
    Abstract: The present invention discloses a method for diagnosing the metabolic syndrome by determination of the afamin content in a sample of a body fluid or a tissue sample, wherein the metabolic syndrome is diagnosed if the afamin content in the sample is increased compared to the afamin content in a sample from a person not having the metabolic syndrome.
    Type: Grant
    Filed: September 4, 2008
    Date of Patent: March 20, 2012
    Assignee: Hans Dieplinger
    Inventors: Hans Dieplinger, Florian Kronenberg, Johann Willeit, Stefan Kiechl, Wolfgang Engel
  • Method for Diagnosing the Metabolic Syndrome (MS)
    Publication number: 20100260771
    Abstract: The present invention discloses a method for diagnosing the metabolic syndrome by determination of the afamin content in a sample of a body fluid or a tissue sample, wherein the metabolic syndrome is diagnosed if the afamin content in the sample is increased compared to the afamin content in a sample from a person not having the metabolic syndrome.
    Type: Application
    Filed: September 4, 2008
    Publication date: October 14, 2010
    Inventors: Hans Dieplinger, Florian Kronenberg, Johann Willeit, Stefan Kiechl, Wolfgang Engel
  • Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations
    Patent number: 7803569
    Abstract: An arterial thrombosis risk factor comprising one or more of the identified mutants of coagulation factor VII activating protease (FSAP) is described. In addition, diagnostic determination methods for detecting these mutants which are identified as risk factors are described.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: September 28, 2010
    Assignee: CSL Behring GmbH
    Inventors: Stefan Kiechl, Johann Willeit, Christian Josef Wiedermann, Juergen Roemisch, Thomas Weimer, Annette Feussner, Hans-Arnold Stoehr, Volker Doersam, Wiegand Lang, Margret Becker, Claudia Nerlich, Gudrun Muth-Naumann, Bernd Knoblauch
  • Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations
    Publication number: 20070099229
    Abstract: A novel arterial thrombosis risk factor comprising one or more of the identified mutants of coagulation factor VII-activating protease (FSAP) is described. In addition, diagnostic determination methods for detecting these mutants which are identified as risk factors are described.
    Type: Application
    Filed: December 5, 2006
    Publication date: May 3, 2007
    Inventors: Stefan Kiechl, Johann Willeit, Christian Wiedermann, Juergen Roemisch, Thomas Weimer, Annette Feussner, Hans-Arnold Stoehr, Volker Doersam, Wiegand Lang, Margret Becker, Claudia Nerlich, Gudrun Muth-Naumann, Bernd Knoblauch
  • Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis
    Patent number: 7153679
    Abstract: A novel arterial thrombosis risk factor comprising one or more of the identified mutants of coagulation factor VII-activating protease (FSAP) is described. In addition, diagnostic determination methods for detecting these mutants which are identified as risk factors are described.
    Type: Grant
    Filed: March 19, 2003
    Date of Patent: December 26, 2006
    Assignee: Aventis Behring GmbH
    Inventors: Stefan Kiechl, Johann Willeit, Christian Josef Wiedermann, Juergen Roemisch, Thomas Weimer, Annette Feussner, Hans-Arnold Stoehr, Volker Doersam, Wiegand Lang, Margret Becker, Claudia Nerlich, Gudrun Muth-Naumann, Bernd Knoblauch
  • Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis
    Publication number: 20040009543
    Abstract: A novel arterial thrombosis risk factor comprising one or more of the identified mutants of coagulation factor VII-activating protease (FSAP) is described. In addition, diagnostic determination methods for detecting these mutants which are identified as risk factors are described.
    Type: Application
    Filed: March 19, 2003
    Publication date: January 15, 2004
    Inventors: Stefan Kiechl, Johann Willeit, Christian Josef Wiedermann, Juergen Roemisch, Thomas Weimer, Annette Feussner, Hans-Arnold Stoehr, Volker Doersam, Wiegand Lang, Margret Becker, Claudia Nerlich, Gudrun Muth-Naumann, Bernd Knoblauch